Evaluation of herbal combination consists of Trigonella, Foeniculum, Chichorium, Hornleum and Glycine in the prevention of cancer-induced cachexia/anorexia of solid tumors’ patients: a randomized, double-blinded, placebo-controlled clinical trial

Esfahan University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新: 2019年8月26日

试验速览

暂无简介。

•All adult patients (18 years and older) with advanced solid tumor malignancies (Stage 3-4) who encountered cancer-induced anorexia or weight loss (equal or greater than 5% of the previous weight before cancer diagnosis or within the last two months).
•Cancer patients with serum creatinine < 2 mg / dl.
•Cancer patients with serum total bilirubin < 2 mg / dl.
•Patients haven't had any sign of dysphagia or gastrointestinal obstruction.
•We have expected patients to be alive at least 3 upcoming months.
•Patients who have received high doses of megestrol due to cachexia and anorexia simultaneously.

•Patients who have undergone major surgery for the last 4 weeks.
•Patients with a history of thrombophlebitis diseases.
•Patients who have been taking systemic corticosteroid within the last 4 weeks or concurrently.
•Patients who have cognitive impairment, psychiatric disorder or brain metastasis leading to cognitive impairment.
•Patients who have diabetes, uncontrolled blood pressure or advanced heart failure (NYHA 4)
•Patients who have consumed chronic alcohol.
•Patients who are pregnant or breast-feeding.
•Patients with a known hypersensitivity reaction to one of the plants in considered herbal combination

发起方